Brief Interventions for Harmful Alcohol Use in Opioid-dependent Patients on Maintenance Treatment With Buprenorphine: A Prospective Study From India

被引:11
|
作者
Varshney, Mohit
Ambekar, Atul [1 ,2 ]
Lal, Rakesh
Yadav, Deepak
Rao, Ravindra
Mishra, Ashwani
机构
[1] All India Inst Med Sci, Dept Psychiat, New Delhi 110029, India
[2] All India Inst Med Sci, Natl Drug Dependence Treatment Ctr, New Delhi 110029, India
来源
ADDICTIVE DISORDERS & THEIR TREATMENT | 2016年 / 15卷 / 03期
关键词
Brief Intervention; harmful alcohol use; buprenorphine; opioid substitution therapy;
D O I
10.1097/ADT.0000000000000076
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction: Harmful/hazardous alcohol use is common among individuals receiving opioid substitution therapy (OST). The World Health Organisation (WHO) recommends use of Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)-linked Brief Interventions (BI) for managing harmful alcohol use. However, the feasibility and effectiveness of BI in addressing harmful alcohol use among buprenorphine-maintained OST recipients has not been studied, which was the objective of the present study. Methods: Using a prospective study design, OST recipients were screened with WHO-ASSIST, and those in the harmful/hazardous use category were administered BI sessions. The feasibility of BI was assessed using BI process rating form. Alcohol-related quantitative variables were assessed with WHO-ASSIST and Rutgers Alcohol Problem Index at baseline and 12 weeks post-BI, and compared for measuring BI effectiveness. Results: Thirty-six (of 138 OST recipients screened) had ASSIST scores in the harmful hazardous category at baseline, and underwent 2 BI sessions at 1 to 2 weeks apart. Of these, 35 patients completed all BI sessions, and baseline and end-line assessments. The average time taken for 1 BI session was 26.43 minutes; 54% reported a "significant influence'' of BI on alcohol consumption; 88% reported that they attempted to cut down alcohol use; 14% completely stopped drinking; and another 14% reported significant reduction in alcohol consumption. ASSIST and Rutgers Alcohol Problem Index scores were significantly reduced at end-line assessment. Conclusion: BI is a feasible and effective intervention to address harmful/hazardous drinking among buprenorphine-maintained opioid-dependent patients.
引用
收藏
页码:129 / 135
页数:7
相关论文
共 50 条
  • [21] Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
    Nasim Zamani
    Nicholas A. Buckley
    Hossein Hassanian-Moghaddam
    Critical Care, 24
  • [22] Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial
    Zamani, Nasim
    Buckley, Nicholas A.
    Hassanian-Moghaddam, Hossein
    CRITICAL CARE, 2020, 24 (01):
  • [23] Baclofen in the treatment of alcohol withdrawal syndrome in opioid-dependent patients
    Gibbons, Zorina
    McCarron, Peter
    Sandal, Kiran
    McCarthy, Roisin
    Keenan, Eamon
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2022, 24 (03) : 21 - 27
  • [24] Safety and Efficacy of Buprenorphine/Naloxone in Opioid-Dependent Patients An Italian Observational Study
    Magnelli, Fernanda
    Biondi, Lorita
    Calabria, Roberto
    Fiore, Angelo
    Peluso, Eugenio
    Vonella, Domenico
    Rota, Amerigo Giuseppe
    CLINICAL DRUG INVESTIGATION, 2010, 30 : 21 - 26
  • [25] Effectiveness and Compliance of Naltrexone in Opioid-dependent Patients: A Pilot Study From India
    Malhotra, Sameer
    Jain, Raka
    Varghese, Sunny
    ADDICTIVE DISORDERS & THEIR TREATMENT, 2006, 5 (03): : 129 - 132
  • [26] Pain severity and subsequent opioid use during buprenorphine-naloxone treatment of prescription opioid-dependent patients with chronic pain
    Weiss, Roger
    Griffin, Margaret L.
    McDermott, Katherine
    McHugh, Kathryn
    Karakula, Sterling L.
    Fitzmaurice, Garrett
    DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E215 - E216
  • [27] Improved Quality of Life for Opioid-Dependent Patients Receiving Buprenorphine Treatment in HIV Clinics
    Korthuis, P. Todd
    Tozzi, Mary Jo
    Nandi, Vijay
    Fiellin, David A.
    Weiss, Linda
    Egan, James E.
    Botsko, Michael
    Acosta, Angela
    Gourevitch, Marc N.
    Hersh, David
    Hsu, Jeffrey
    Boverman, Joshua
    Altice, Frederick L.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 : S39 - S45
  • [28] Effect Of Exercise Training On Alcohol And Substitute Use In Opioid-dependent Patients During Substitution Treatment
    Psarianos, Alexandros Elissaios
    Chryssanthopoulos, Costas
    Paparrigopoulos, Thomas
    Philippou, Anastassios
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 1046 - 1047
  • [29] Marijuana use and treatment outcome among opioid-dependent patients
    Budney, AJ
    Bickel, WK
    Amass, L
    ADDICTION, 1998, 93 (04) : 493 - 503
  • [30] Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
    Perrine Roux
    Daniela Rojas Castro
    Khadim Ndiaye
    Laélia Briand Madrid
    Virginie Laporte
    Marion Mora
    Gwenaelle Maradan
    Stéphane Morel
    Bruno Spire
    Patrizia Carrieri
    Substance Abuse Treatment, Prevention, and Policy, 12